Gut microbiome/metabolome predicts response to immune checkpoint blockers (ICB) in patients with recurrent metastatic head and neck squamous cell cancer (RM HNSCC).
Publication
, Conference
Bari, S; Jain, S; Yadav, H; Liu, M; Hodge, E; Kirtane, K; Chung, CH; Conejo-Garcia, J; Muzaffar, J
Published in: JOURNAL OF CLINICAL ONCOLOGY
2022
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2022
Volume
40
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Bari, S., Jain, S., Yadav, H., Liu, M., Hodge, E., Kirtane, K., … Muzaffar, J. (2022). Gut microbiome/metabolome predicts response to immune checkpoint blockers (ICB) in patients with recurrent metastatic head and neck squamous cell cancer (RM HNSCC). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).
Bari, Shahla, Shalini Jain, Hariom Yadav, Min Liu, Eli Hodge, Kedar Kirtane, Christine H. Chung, Jose Conejo-Garcia, and Jameel Muzaffar. “Gut microbiome/metabolome predicts response to immune checkpoint blockers (ICB) in patients with recurrent metastatic head and neck squamous cell cancer (RM HNSCC).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.
Bari S, Jain S, Yadav H, Liu M, Hodge E, Kirtane K, et al. Gut microbiome/metabolome predicts response to immune checkpoint blockers (ICB) in patients with recurrent metastatic head and neck squamous cell cancer (RM HNSCC). In: JOURNAL OF CLINICAL ONCOLOGY. 2022.
Bari, Shahla, et al. “Gut microbiome/metabolome predicts response to immune checkpoint blockers (ICB) in patients with recurrent metastatic head and neck squamous cell cancer (RM HNSCC).” JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022.
Bari S, Jain S, Yadav H, Liu M, Hodge E, Kirtane K, Chung CH, Conejo-Garcia J, Muzaffar J. Gut microbiome/metabolome predicts response to immune checkpoint blockers (ICB) in patients with recurrent metastatic head and neck squamous cell cancer (RM HNSCC). JOURNAL OF CLINICAL ONCOLOGY. 2022.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2022
Volume
40
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences